IMI (Innovative medicines initiative) several calls

Call identifier: H2020-JTI-IMI2-2017-12-TWO-STAGE (deadlines: 26 October 2017 & 16 May 2018)

Link to the call

IMI2-2017-12-01: Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s Disease (RADAR-AD)

IMI2-2017-12-02: FAIRification of IMI and EFPIA data

IMI2-2017-12-03: Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS)

IMI2-2017-12-04: European Health Data Network (EHDN)

IMI2-2017-12-05: Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations

IMI2-2017-12-06: Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolic diseases

IMI2-2017-12-07: European Screening Centre: unique library for attractive biology (ESCulab)

Published July 20, 2017 11:15 AM - Last modified July 20, 2017 11:15 AM